Pura Vida Investments Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$30.5M |
| 2 |
Intuitive Surgical
ISRG
|
+$9.09M |
| 3 |
Glaukos
GKOS
|
+$7.06M |
| 4 |
Metagenomi Therapeutics
MGX
|
+$5.3M |
| 5 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
+$3.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
|
+$328M |
| 2 |
Quanterix
QTRX
|
+$6.82M |
| 3 |
Establishment Labs
ESTA
|
+$6.28M |
| 4 |
Avita Medical
RCEL
|
+$5.28M |
| 5 |
Insulet
PODD
|
+$2.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.77% |
| 2 | Consumer Discretionary | 0% |
Similar funds
Pura Vida Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Pura Vida Investments held 76 positions worth $593M, down 9.5% from $656M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Pura Vida Investments withdrew a net $26.5M in Q1 2024, closing 25 positions and reducing 12 holdings. Its most notable exit was MedAvail Holdings, Inc. Common Stock, an estimated $328M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 64% a quarter earlier, followed by Consumer Discretionary.
Against the trend, Pura Vida Investments opened a new position in Exact Sciences worth $33.3M.
- Pura Vida Investments's largest Q1 2024 buy was Exact Sciences: 481,910 shares worth $33.3M.
- Pura Vida Investments added most to AdvisorShares Pure US Cannabis ETF in Q1 2024, an estimated $3.52M increase.
- Pura Vida Investments's biggest Q1 2024 reduction was Quanterix, cutting an estimated $6.82M.
- Pura Vida Investments fully exited MedAvail Holdings, Inc. Common Stock in Q1 2024, selling an estimated $328M.
- Pura Vida Investments's ten largest holdings make up 74% of its $593M portfolio in Q1 2024.
- Pura Vida Investments opened 22 new positions and closed 25 in Q1 2024.
- Pura Vida Investments's portfolio value fell 9.5% quarter-over-quarter to $593M.
Based on Pura Vida Investments's 13F filing for Q1 2024, filed 15 May 2024.